Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

Aim: The study aims to evaluate protective effects of sophoricoside (Sop) on cardiac hypertrophy. Meanwhile, the potential and significance of Sop should be broadened and it should be considered as an attractive drug for the treatment of pathological cardiac hypertrophy and heart failure. Methods: U...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Maomao, Hu, Fengjiao, Hu, Manli, Hu, Yufeng, Shi, Hongjie, Zhao, Guo-Jun, Jian, Chongshu, Ji, Yan-Xiao, Zhang, Xiao-Jing, She, Zhi-Gang, Li, Hongliang, Zhu, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cardiovascular System & Vascular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677750/
https://www.ncbi.nlm.nih.gov/pubmed/32964914
http://dx.doi.org/10.1042/BSR20200661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677750/
https://www.ncbi.nlm.nih.gov/pubmed/32964914
http://dx.doi.org/10.1042/BSR20200661

Ejemplares similares